Two Dose Levels of DFN-15 vs. Placebo in Patients With Migraine Headaches
NCT02472418 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 63
Last updated 2018-05-22
Summary
Crossover study of DFN-15 dose A versus DFN-15 dose B versus Placebo in the treatment of migraine headaches.
Conditions
Interventions
- DRUG
-
DFN-15 Dose A (treatment A)
DFN-15 Dose A administered
- DRUG
-
DFN-15 Dose B (treatment B)
DFN-15 Dose B administered
- OTHER
-
Placebo (treatment C)
Placebo administered
Sponsors & Collaborators
-
Dr. Reddy's Laboratories Limited
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-06-05
- Primary Completion
- 2015-12-01
- Completion
- 2016-05-05
Countries
- United States
Study Locations
More Related Trials
-
Study on the Pharmacokinetics (PK) of DFN-15 vs Comparator and Food-effect on DFN-15 PK in Healthy Adult Subjects
NCT03282838 ·Status: COMPLETED ·Phase: PHASE1
-
DFN-11 Injection in Episodic Migraine With or Without Aura
NCT02569853 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Determine the Efficacy and Safety of ELS-M11 in Acute Migraine
NCT02057315 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Effect of Sumatriptan and Placebo on Isosorbide-5-mononitrate Induced Headache
NCT02485340 ·Status: COMPLETED ·Phase: NA
-
A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
NCT06602479 ·Status: RECRUITING ·Phase: PHASE2
-
R-Verapamil for the Prophylaxis of Episodic Cluster Headache
NCT02209155 ·Status: TERMINATED ·Phase: PHASE2
-
A Dose-Finding Study of MK0974 in Acute Migraine (MK0974-004)
NCT00246337 ·Status: COMPLETED ·Phase: PHASE2
-
Idebenone for the Preventive Treatment of Migraine
NCT04151472 ·Status: RECRUITING ·Phase: PHASE3
-
Pilot Study of DFN-11 Injection in Medication Overuse Headache
NCT02583425 ·Status: TERMINATED ·Phase: PHASE2
-
An Efficacy and Safety Study of DFN-02 (Sumatriptan Nasal Spray 10 mg)
NCT02856802 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens
NCT05217927 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy Study of MK0974 in the Acute Migraine (0974-016)
NCT00432237 ·Status: COMPLETED ·Phase: PHASE3
-
Low-Dose Naltrexone and Acetaminophen Combination and Sumatriptan in the Acute Treatment of Migraine With Nausea
NCT03185143 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study of K-645 in the Treatment of Multiple Migraine Attacks
NCT07116499 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of the Efficacy and Safety of Topiramate in the Prevention of Migraine
NCT00231595 ·Status: COMPLETED ·Phase: PHASE3
-
An Acute Migraine Factorial Study
NCT06245902 ·Status: COMPLETED ·Phase: PHASE2
-
The Evolution and Management of Migraine Recurrence Beyond 24 Hours
NCT00754611 ·Status: COMPLETED
-
Safety and Efficacy of ZP-Zolmitriptan Intracutaneous Microneedle Systems for the Acute Treatment of Migraine
NCT02745392 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy of Sumatriptan With Naprosyn in Migraine With Aura
NCT00893594 ·Status: UNKNOWN ·Phase: NA
-
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
NCT00724815 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Efficacy and Safety of AMG 301 in Migraine Prevention
NCT03238781 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized,Double Blind, Placebo Controlled Study to Assess Efficacy,Safety and Tolerability of BGG492 in Migraine Prevention
NCT01617941 ·Status: WITHDRAWN ·Phase: PHASE2
-
Calcitonin Gene-related Peptide in Familial Hemiplegic Migraine (FHM) and Migraine With Aura (MA)
NCT00687947 ·Status: COMPLETED ·Phase: NA
-
Rizatriptan 10 MG RPD in the Treatment of Acute Migraine
NCT01057160 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Sumatriptan on Levcromakalim-Induced Symptoms in Individuals With Migraine
NCT05211050 ·Status: COMPLETED ·Phase: NA